Previous 10 | Next 10 |
Gainers: Snap (NYSE:SNAP) +52%. Bill.com Holdings (NYSE:BILL) +31%. Indonesia Energy Corporation (NYSE:INDO) +28%. eGain (NASDAQ:EGAN) +22%. Sphere (NASDAQ:ANY) +21%. Standard Lithium (NYSE:SLI) +17%. Aurora Innovation (NASDAQ:AUR) +17%. Unity Software (NYSE:U) +17%. Astria Therapeutics (NASD...
Pro-Dex press release (NASDAQ:PDEX): FQ2 GAAP EPS of $0.25. Revenue of $10.17M (+22.5% Y/Y). For further details see: Pro-Dex GAAP EPS of $0.25, revenue of $10.17M
IRVINE, CA / ACCESSWIRE / February 3, 2022 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2022 second quarter ended December 31, 2021. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2022 with the Securities and E...
Avoiding – not evading – the IRS. Income tax minimization and estate tax avoidance. And my favorite tax-loss harvesting opportunities. For further details see: 3 Ways To Beat The Tax Man: Amplify Energy, Pro-Dex And 1847 Goedeker
IRVINE, CA / ACCESSWIRE / November 15, 2021 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2022 first quarter ended September 30, 2021. The Company also filed its Quarterly Report on Form 10-Q for the first quarter of fiscal year 2022 with the Securities and...
Long Cast Advisers, LLC, is an independent registered investment adviser investing on behalf of individuals, family offices and endowments. It is concentrated on long-term investing, focused on small-cap companies. For the 3Q21 quarter (ended September 30 2021), cumulative net returns...
Gainers: NeuroMetrix (NASDAQ:NURO) +54%, Reneo Pharmaceuticals (NASDAQ:RPHM) +24%, Neoleukin Therapeutics (NASDAQ:NLTX) +21%, Chembio Diagnostics (NASDAQ:CEMI) +17%, InspireMD (NASDAQ:NSPR) +14%. Losers: Cassava Sciences (NASDAQ:SAVA) -28%, Applied Ther...
Pro-Dex (NASDAQ:PDEX): Q4 GAAP EPS of $0.22 misses by $0.07. Revenue of $9.4M (-15.5% Y/Y) misses by $1M. Shares -2.1%. Press Release For further details see: Pro-Dex EPS misses by $0.07, misses on revenue
IRVINE, CA / ACCESSWIRE / August 26, 2021 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2021 fourth quarter and full-year ended June 30, 2021. Quarter Ended June 30, 2021 Net sales for the three months ended June 30, 2021 decreased $1.7 million, or15%...
Pro-Dex should benefit from hospitals returning to normal, with an uptick in surgery procedures during 2022 vs. the pandemic restrictions of 2020-21. New products are being introduced later this year. The stock valuation remains cheap, if business growth continues into next year. ...
News, Short Squeeze, Breakout and More Instantly...
2024-05-23 06:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-03 12:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
IRVINE, CA / ACCESSWIRE / May 2, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 third quarter ended March 31, 2024. The Company also filed its Quarterly Report on Form 10-Q for the third quarter of fiscal year 2024 with the Securities and Exchange Commis...